Home > Jean Claude Tardif, AHA 2019 – Results from the COLCOT trial
Cardiovascular disease

Jean Claude Tardif, AHA 2019 – Results from the COLCOT trial

Published Online: December 12th 2019

Jean-Claude Tardif (Director of the Research Centre, Montreal Heart Institute and Professor of Medicine, University of Montreal, Montreal, QC, Canada) reviews the results from the COLchicine Cardiovascular Outcomes Trial (COLCOT), presented at the American Heart Association (AHA) Scientific Sessions 2019.

Speaker’s Disclosures: Dr. Tardif reports grants from Government of Quebec; grants from Amarin, grants and personal fees from Astra Zeneca, grants, personal fees and other from DalCor, grants from Esperion, grants from Ionis, grants and personal fees from Pfizer, grants and personal fees from Sanofi, grants and personal fees from Servier.

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Related Videos In Cardiovascular disease
  • Journal articles and more to your inbox

    Get the latest clinical insights from touchCARDIO

    Sign me up!
    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowlinkmenumore_dots padlock person play-colourAsset 1podcastprinter search share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrow